Accolade Inc. (ACCD): Price and Financial Metrics

Accolade Inc. (ACCD): $17.97

-0.77 (-4.11%)

POWR Rating

Component Grades













Add ACCD to Watchlist
Sign Up

Industry: Internet


of 77

in industry


  • ACCD scores best on the Sentiment dimension, with a Sentiment rank ahead of 63.95% of US stocks.
  • ACCD's strongest trending metric is Stability; it's been moving down over the last 163 days.
  • ACCD ranks lowest in Growth; there it ranks in the 7th percentile.

ACCD Stock Summary

  • ACCD's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 3.64 -- higher than merely 15.11% of US-listed equities with positive expected earnings growth.
  • ACCD's went public 1.56 years ago, making it older than just 2.65% of listed US stocks we're tracking.
  • The volatility of Accolade Inc's share price is greater than that of 86.14% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Accolade Inc, a group of peers worth examining would be CORT, UTHR, YELP, EVR, and STEP.
  • ACCD's SEC filings can be seen here. And to visit Accolade Inc's official web site, go to

ACCD Valuation Summary

  • ACCD's price/sales ratio is 16.4; this is 200.92% higher than that of the median Technology stock.
  • Over the past 14 months, ACCD's price/earnings ratio has gone down 10.1.
  • ACCD's EV/EBIT ratio has moved down 9.5 over the prior 14 months.

Below are key valuation metrics over time for ACCD.

Stock Date P/S P/B P/E EV/EBIT
ACCD 2021-09-01 16.4 7.3 -37.3 -38.1
ACCD 2021-08-31 16.1 7.2 -36.7 -37.5
ACCD 2021-08-30 16.1 7.1 -36.5 -37.3
ACCD 2021-08-27 16.0 7.1 -36.2 -37.0
ACCD 2021-08-26 15.1 6.7 -34.3 -35.0
ACCD 2021-08-25 14.9 6.6 -33.9 -34.6

ACCD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ACCD has a Quality Grade of D, ranking ahead of 16.91% of graded US stocks.
  • ACCD's asset turnover comes in at 0.297 -- ranking 433rd of 561 Business Services stocks.
  • 500 - Internal server error

The table below shows ACCD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-08-31 0.297 0.433 -2.101
2021-05-31 0.369 0.447 -2.074
2021-02-28 0.512 0.450 2.793
2020-02-28 1.906 0.444 3.310
2020-02-28 1.906 0.444 3.310
2020-02-28 1.906 0.444 3.310

ACCD Price Target

For more insight on analysts targets of ACCD, see our ACCD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $63.00 Average Broker Recommendation 1.18 (Strong Buy)

ACCD Stock Price Chart Interactive Chart >

Price chart for ACCD

ACCD Price/Volume Stats

Current price $17.97 52-week high $59.69
Prev. close $18.74 52-week low $17.53
Day low $17.77 Volume 983,200
Day high $18.93 Avg. volume 1,679,971
50-day MA $25.72 Dividend yield N/A
200-day MA $41.12 Market Cap 1.20B

Accolade Inc. (ACCD) Company Bio

Accolade, Inc. is an emerging growth company, which engages in the provision of personalized, technology-enabled solutions through a technology platform. It offers Accolade Total Benefits and Accolade Total Care. Accolade Total Benefits focuses on member benefits engagement and Accolade Total Care help guides members to healthcare providers. The company was founded by Thomas K. Spann and J. Michael Cline in 2007 and is headquartered in Seattle, WA.

ACCD Latest News Stream

Event/Time News Detail
Loading, please wait...

ACCD Latest Social Stream

Loading social stream, please wait...

View Full ACCD Social Stream

Latest ACCD News From Around the Web

Below are the latest news stories about Accolade Inc that investors may wish to consider to help them evaluate ACCD as an investment opportunity.

Accolade (ACCD) Received its Third Buy in a Row

After Bank of America Securities and Leerink Partners gave Accolade (NASDAQ: ACCD) a Buy rating last month, the company received another Buy, this time from Needham. Analyst Ryan MacDonald maintained a Buy rating on Accolade today and set a price target of $33.00. The company's shares closed last Friday at $20.21, close to its 52-week low of $18.72. According to, MacDonald is a 5-star analyst with an average return of 22.5% and a 52.1% success rate. MacDonald covers the Technology sector, focusing on stocks such as Zeta Global Holdings Corp, Momentive Global, and Verint Systems.

Brian Anderson on TipRanks | January 18, 2022

Company News for Jan 12, 2022

Companies in The News Are: ACCD,PACB,BIG,ILMN

Yahoo | January 12, 2022

Accolade, Inc. 2022 Q3 - Results - Earnings Call Presentation

The following slide deck was published by Accolade, Inc. in conjunction with their 2022 Q3 earnings call....

SA Transcripts on Seeking Alpha | January 11, 2022

Accolade, Inc.'s (ACCD) CEO Rajeev Singh on Q3 2022 Results - Earnings Call Transcript

Accolade, Inc. (ACCD) Q3 2022 Earnings Conference Call January 10, 2022, 4:30 PM ET Company Participants Todd Friedman - Senior Vice President, Investor Relations Rajeev Singh - Chief Executive Officer Steve Barnes - Chief Financial Officer Shantanu Nundy - Chief Medical Officer Conference Call Participants Ryan Daniels - William Blair...

SA Transcripts on Seeking Alpha | January 11, 2022

Accolade Posts Stellar Q3 Results; Shares Up 11.3%

Accolade, Inc. (NASDAQ: ACCD) reported stronger-than-expected fiscal Q3 results driven by higher-than-expected performance-based revenues. Notably, the company also issued impressive preliminary guidance for the fiscal year 2023. Following the earnings announcement and optimistic guidance, shares of the technology-driven benefits and health utilization software provider gained 11.3% during the extended trading session on January 10. Stellar Q3 Outperformance Notably, adjusted third-quarter earnings of 31 cents per share were significantly higher than the loss of 32 cents reported in the prior-year period, and exceeded analysts’ expectations of a loss of 74 cents per share. Furthermore, revenues of $83.5 million in the quarter more than doubled compared to $38.

Devina Lohia on TipRanks | January 11, 2022

Read More 'ACCD' Stories Here

ACCD Price Returns

1-mo N/A
3-mo -54.84%
6-mo -61.99%
1-year -69.59%
3-year N/A
5-year N/A
YTD -31.83%
2021 -39.40%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8096 seconds.